The antimicrobial resistance monitoring and research (ARMoR) program: The US department of defense response to escalating antimicrobial resistance

Clinical Infectious Diseases

Volumn 59, Issue 3, 2014, Pages 390-397

  Lesho, Emil P ^a,c   Waterman, Paige E ^a,b,c   Chukwuma, Uzo ^d   McAuliffe, Kathryn ^d   Neumann, Charlotte ^d   Julius, Michael D ^a   Crouch, Helen ^e   Chandrasekera, Ruvani ^b   English, Judith F ^f   Clifford, Robert J ^a   Kester, Kent E ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Global Emerging Infections Surveillance and Response System   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d Navy and Marine Corps Public Health Center   (United States)

^e BROOKE ARMY MEDICAL CENTER   (United States)

^f US Navy Bureau of Medicine and Surgery   (United States)

Author keywords

Antimicrobial resistance; Department of Defense; Infection prevention; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; BACTERIUM; CROSS INFECTION; DRUG EFFECTS; EPIDEMIOLOGICAL MONITORING; GOVERNMENT; RESEARCH; UNITED STATES;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; RESEARCH; UNITED STATES; UNITED STATES DEPARTMENT OF DEFENSE;

EID: 84905025063     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu319     Document Type: Review

References (34)

1. Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antimicrobials. Clin Infect Dis 2013; 56: 1445-50.
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis 2011; 53: 60-7.
3. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Cont Hosp Epidemiol 2013; 34: 1-14.
4. Rempel OR, Laupland KB. Surveillance for antimicrobial resistant organisms: potential sources and magnitude of bias. Epidemiol Infect 2009; 137: 1665-73.
5. Monnet DL, Lopez-Lozano JM, Campillos P, Burgos A, Yague A, Gonzalo N. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect Dis 2001; 7(SUPPL. 5): 29-36.
6. Sanchez GV, Master RN, Clark RB, et al. Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010. Emerg Infect Dis 2013; 19: 133-6.
7. Lesho E, Gleeson T, Summers A, et al. Joint collaboration enhances infection control at home and abroad: the maiden voyage of the Multidrug-Resistant Organism Repository and Surveillance Network. Mil Med 2011; 176: 241-3.
8. Lesho E, Craft D, Kirkup BC Jr, et al. Surveillance, characterization, and preservation of multidrug-resistant bacteria. Lancet Infect Dis 2011; 11: 8-10.
9. Waterman P, Kwak Y, Clifford R, et al. A multidrug-resistance surveillance network: 1 year on. Lancet Infect Dis 2012; 12: 587-8.
10. Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012; 308: 50-9.
11. Clifford RJ, Milillo M, Prestwood J, et al. Detection of bacterial 16S rRNA and identification of four clinically important bacteria by realtime PCR. PLoS One 2012; 7:e48558.
12. NDM using multiplex real-time PCR. J Clin Microbiol 2013; 51: 1247-9.
13. McGann P, Kwak YI, Summers A, Cummings JF, Waterman PE, Lesho EP. Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States. Infect Control Hosp Epidemiol 2011; 32: 1116-9.
14. NDM-1 carbapenem resistance in a clinical isolate of Providencia stuartii in a U.S./coalition medical facility - Afghanistan, 2011. Morb Mortal Wkly Rep 2011; 60: 756.
15. Ake J, Scott P, Wortmann G, et al. Gram-negative multidrug-resistant organism colonization in a U.S. military healthcare facility in Iraq. Infect Control Hosp Epidemiol 2011; 32: 545-52.
16. Huang XZ, Cash DM, Chahine MA, et al. Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq. Epidemiol Infect 2010; 23: 1-4.
17. Lesho E, Ake J, Huang X, et al. Amount of usage and involvement in explosions were not associated with increased contamination of prehospital vehicles with multidrug-resistant organisms. Prehosp Disaster Med 2013; 28: 107-9.
18. Lesho E, Clifford R, Nielsen L, et al. 2013 update of the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN): synergy through interagency collaboration and applied research. C2-1650c. Presented at: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2013; Denver, CO.
19. Lesho E, Yoon EJ, McGann P, et al. Emergence of colistin-resistance in Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of extremely-drug-resistant wound infections. J Infect Dis 2013; 208: 1142-51.
20. NDM-1 in a Providencia stuartii strain isolated in Afghanistan. Antimicrob Agents Chemother 2012; 56: 1673-9.
21. NDM-1) in Acinetobacter schindleri during routine surveillance. J Clin Microbiol 2013; 51: 1942-4.
22. Waterman PR, McGann P, Snesrud E, et al. Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne New Delhi metallo-β-lactamase in Honduras. Antimicrob Agents Chemother 2013; 57: 4584-6.
23. McGann P, Milillo M, Kwak Y, Quintero R, Waterman PE, Lesho E. Rapid and simultaneous detection of the chlorhexidine and mupirocin resistance genes qacA/B and mupA in clinical isolates of methicillin-resistant Staphylococcus aureus. Diag Microbiol Infect Dis 2013; 77: 270-2.
24. Clifford RJ, Hang J, Riley MC, et al. Complete genome sequence of Providencia stuartii clinical isolate MRSN 2154. J Bacteriol 2012; 194: 3736-7.
25. Onmus-Leone F, Hang J, Clifford RJ, et al. Enhanced de novo assembly of high throughput pyrosequencing data using whole genome mapping. PLoS One 2013; 8:e61762.
26. VIM-2 in a novel species of Pseudomonas isolated from a urinary tract infection. C2-1609a. Presented at: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2013; Denver, CO.
27. Neilsen LE, Snesrud E, Onmus-Leone F, et al. Elucidating the mechanism of tigecycline resistance in Klebsiella pneumoniae isolates from a Honduran neonate. C1-1088. Presented at: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2013; Denver, CO.
28. Onmus-Leone F, McGann P, Snesrud E, et al. Comparative genomics of two Klebsiella pneumoniae isolated from a recurrent wound infection three years apart. C2-073a. Presented at: 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 2013; Denver, CO.
29. O'Hara JA, McGann P, Snesrud EC, et al. Novel 16S ribosomal RNA methyltransferase RmtH produced by Klebsiella pneumoniae associated with war-related trauma. Antimicrob Agents Chemother 2013; 57: 2413-6.
30. Riley MC, Lee JE, Lesho E, Kirkup BC Jr Optically mapping multiple bacterial genomes simultaneously in a single run. PLoS One 2011; 6: e27085.
31. Clifford RJ, Snesrud EC, Onmus-Leone F, et al. Genomic characterization of a novel Acinetobacter baumannii strain associated with fatal infections reveals unusual virulence determinants control. 3189. Presented at: 114th General Meeting of the American Society for Microbiology; May 2014; Boston, MA.
32. Clifford RS, Clifford RJ, Waterman PE, Lesho EP. MDRevealer: a new software program to accelerate the identification multi-, extensively, and pan-drug resistant bacteria control. 3219. Presented at: 114th General Meeting of the American Society for Microbiology; May 2014; Boston, MA.
33. Lesho EP, Clifford RJ, Chukwuma U. The burden of carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in a U.S. national managed care system. 6141. Presented at: Spring 2014 Conference of the Society for Healthcare Epidemiology of America; April 2014; Denver, CO.
34. Hosford E, Clifford RJ, Chukwuma U, et al. The effect of evidence-based design on MDRO in a new hospital. 6035. Presented at: Spring 2014 Conference of the Society for Healthcare Epidemiology of America; April 2014; Denver, CO.